These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. Procopio M, Maccario M, Savio P, Valetto MR, Aimaretti G, Grottoli S, Oleandri SE, Baffoni C, Tassone F, Arvat E, Camanni F, Ghigo E. Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747 [Abstract] [Full Text] [Related]
4. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. Procopio M, Maccario M, Savio P, Valetto MR, Aimaretti G, Grottoli S, Oleandri SE, Baffoni C, Tassone F, Arvat E, Camanni F, Ghigo E. Minerva Endocrinol; 1999 Mar; 24(3-4):107-11. PubMed ID: 10953725 [Abstract] [Full Text] [Related]
5. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. Maccario M, Aimaretti G, Grottoli S, Gauna C, Tassone F, Corneli G, Rossetto R, Wu Z, Strasburger CJ, Ghigo E. Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509 [Abstract] [Full Text] [Related]
7. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol]. Robaczyk MG. Ann Acad Med Stetin; 2002 Aug; 48():283-300. PubMed ID: 14601484 [Abstract] [Full Text] [Related]
10. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome. Grugni G, Marzullo P, Ragusa L, Sartorio A, Trifirò G, Liuzzi A, Crinò A, Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology. Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242 [Abstract] [Full Text] [Related]
19. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures]. Kuzma M, Payer J. Cas Lek Cesk; 2010 Oct; 149(5):211-6. PubMed ID: 20629339 [Abstract] [Full Text] [Related]